Bio Solution Co Ltd
KOSDAQ:086820
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Motrex Co Ltd
KOSDAQ:118990
|
KR |
|
L
|
Laredo Petroleum Inc
F:8LP1
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
B
|
Bio Solution Co Ltd
KOSDAQ:086820
|
269.5B KRW |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Bio Solution Co Ltd
Glance View
Bio Solution Co. Ltd. engages in the development of cell therapy products and stem cell applied technologies based on tissue engineering and stem cell technologies. The company is headquartered in Seoul, Seoul and currently employs 97 full-time employees. The company went IPO on 2018-08-20. is a Korea based company mainly engaged in the manufacturing and distribution of cell therapy products. The firm manufactures and sells cell based cosmetic raw materials and therapeutics with background in somatic and stem cell technology. The Company’s major products include cosmetic raw material called stem water, which contains human stem cells has whitening and anti-wrinkling effects; as well as keratinocyte medication for severe burns and chondrocyte therapy product used to cure arthritis. The firm also researches and develops human tissue models for toxicity and efficacy testing using tissue engineering technology.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Bio Solution Co Ltd is 63.6%, which is above its 3-year median of 63.3%.
Over the last 3 years, Bio Solution Co Ltd’s Gross Margin has increased from 57.6% to 63.6%. During this period, it reached a low of 57.6% on Sep 30, 2022 and a high of 64.7% on Dec 31, 2023.
